GH35 / Genhouse Bio - LARVOL DELTA

Dose Finding Study of GH35 in Patients With Advanced Solid Tumors (clinicaltrials.gov) - P1 | N=18 | Active, not recruiting | Sponsor: Suzhou Genhouse Bio Co., Ltd. | Recruiting ➔ Active, not recruiting | N=38 ➔ 18

Enrollment change • Enrollment closed • Oncology • Sarcoma • Solid Tumor • KRAS